Labour attacks New Zealand's health reforms
This article was originally published in Clinica
New Zealand's healthcare system has become "a bureaucratic nightmare more concerned with financial risk management than giving people operations", claims Labour health spokesperson Lianne Dalziel. Ms Dalziel has seized on criticism of the health service by the former head of New Zealand's largest crown health enterprise (CHE), Auckland Healthcare, as proof that the country's health reforms are failing, reports GP Weekly.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.